Ekso Bionics Inc. recently announced it has received FDA clearance to market its Ekso GT robotic exoskeleton to treat patients with hemiplegia due to stroke, patients with spinal cord injuries at levels T4 through L5 and patients with spinal cord…
Ekso Bionics Inc. recently announced it has received FDA clearance to market its Ekso GT robotic exoskeleton to treat patients with hemiplegia due to stroke, patients with spinal cord injuries at levels T4 through L5 and patients with spinal cord…